國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁 到查詢結果 [ subject:"Obstetrics/Perinatology." ]

切換: 標籤 | MARC模式 | ISBD

Drugs during pregnancymethodological...

Kallen, Bengt.

Drugs during pregnancymethodological aspects /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Drugs during pregnancyby Bengt Kallen.
其他題名:	methodological aspects /
作者:	Kallen, Bengt.
出版者:	Cham :Springer International Publishing :2016.
面頁冊數:	xi, 111 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Obstetrical pharmacology.
電子資源:	http://dx.doi.org/10.1007/978-3-319-40697-8
ISBN:	9783319406978$q(electronic bk.)

Drugs during pregnancymethodological aspects /
Kallen, Bengt.

Drugs during pregnancymethodological aspects /[electronic resource] :by Bengt Kallen. - Cham :Springer International Publishing :2016. - xi, 111 p. :ill., digital ;24 cm.

Introduction -- The alert clinician -- Animal experiments and adverse drug reaction reports -- Some epidemiological principles -- Pregnancy outcomes with the exception of congenital malformations -- Congenital malformations -- Identification of maternal use of drugs -- The problem of confounding -- Statistics -- Lumping or splitting? Paternal use of drugs -- Timing of drug use and effects on the embryo or fetus -- Repeated studies and meta-analysis -- Pharmacovigilance -- Information on the risk with drug use during pregnancy -- Concluding remarks.

This book addresses methodological aspects of epidemiological studies on maternal drug use in pregnancy. Discussing the existing sources of error and how they can produce incorrect conclusions, it examines various epidemiological techniques and assesses their strengths and weaknesses. These refer both to the identification of outcomes (with special emphasis on congenital malformations) and to the types of exposure (drug use) Further, the book discusses the problem of confounding and how to handle it, and provides a simple introduction to statistics. Special situations, e.g. different types of parental exposure, are examined. Lastly, the book discusses pharmacovigilance and the information problem, concluding with a short list of aspects to consider when one wants to evaluate a published paper in the field. Though the book is primarily intended for pharmacologists, gynecologists and obstetricians, it will benefit all doctors working in perinatal care.

ISBN: 9783319406978$q(electronic bk.)

Standard No.: 10.1007/978-3-319-40697-8doiSubjects--Topical Terms:

458854
Obstetrical pharmacology.

LC Class. No.: RG528

Dewey Class. No.: 618.2061

Drugs during pregnancymethodological aspects /
LDR:02423nmm a2200313 a 4500 001 497630
003 DE-He213
005 20160909143543.0
006 m d
007 cr nn 008maaau
008 170420s2016 gw s 0 eng d
020 $a 9783319406978$q(electronic bk.)
020 $a 9783319406961$q(paper)
024 7 $a 10.1007/978-3-319-40697-8 $2 doi
035 $a 978-3-319-40697-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RG528
072 7 $a MJT $2 bicssc
072 7 $a MED033000 $2 bisacsh
082 0 4 $a 618.2061 $2 23
090 $a RG528 $b .K14 2016
100 1 $a Kallen, Bengt. $3 676428
245 1 0 $a Drugs during pregnancy $h [electronic resource] : $b methodological aspects / $c by Bengt Kallen.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xi, 111 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction -- The alert clinician -- Animal experiments and adverse drug reaction reports -- Some epidemiological principles -- Pregnancy outcomes with the exception of congenital malformations -- Congenital malformations -- Identification of maternal use of drugs -- The problem of confounding -- Statistics -- Lumping or splitting? Paternal use of drugs -- Timing of drug use and effects on the embryo or fetus -- Repeated studies and meta-analysis -- Pharmacovigilance -- Information on the risk with drug use during pregnancy -- Concluding remarks.
520 $a This book addresses methodological aspects of epidemiological studies on maternal drug use in pregnancy. Discussing the existing sources of error and how they can produce incorrect conclusions, it examines various epidemiological techniques and assesses their strengths and weaknesses. These refer both to the identification of outcomes (with special emphasis on congenital malformations) and to the types of exposure (drug use) Further, the book discusses the problem of confounding and how to handle it, and provides a simple introduction to statistics. Special situations, e.g. different types of parental exposure, are examined. Lastly, the book discusses pharmacovigilance and the information problem, concluding with a short list of aspects to consider when one wants to evaluate a published paper in the field. Though the book is primarily intended for pharmacologists, gynecologists and obstetricians, it will benefit all doctors working in perinatal care.
650 0 $a Obstetrical pharmacology. $3 458854
650 0 $a Pregnant women $x Drug use. $3 504674
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Obstetrics/Perinatology. $3 273827
650 2 4 $a Pharmacotherapy. $3 615025
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-40697-8
950 $a Medicine (Springer-11650)